Document is current
Any future updates will be listed below
-
Authors
Bachanova, Veronika https://orcid.org/0000-0002-9325-432X
Nachman, Patrick H.
- License Information
-
More Information
Article History
Received: 26 July 2023
Revised: 2 August 2023
Accepted: 9 August 2023
First Online: 19 August 2023
Competing interests
: VB has received research funding from Gamida Cell, Incyte, Citius, FATE Therapeutics. DSMB Board Member at Miltenyi; Advisory Board: Astra Zeneca, BeiGene, Allogene, Takeda, Caribou Bioscences, ADC. PHN: No conflicts of interest.
Free to read: This content has been made available to all.
